HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy.

Abstract
Panniculitis is a recognized but unusual complication of a severe deficiency of alpha1-antitrypsin (AAT), with fewer than 100 cases described to date. Like the pathogenesis of emphysema in severe PiZZ deficiency of AAT, panniculitis has been hypothesized to be an inflammatory process, possibly related to Z AAT polymer formation and to an unopposed anti-inflammatory screen in the context of deficient serum levels of AAT. The current report presents a 31-year-old woman with PiZZ AAT deficiency-associated panniculitis. Our case extends current knowledge of AAT-associated panniculitis in 2 ways: (1) we demonstrate Z-type AAT polymers in the skin, which supports the inflammatory pathogenesis of panniculitis and the potential pro-inflammatory role of polymers; (2) we show that a high dose and long-term use of intravenous augmentation therapy (90 mg/kg body weight once weekly during 3 years) can ameliorate the frequency and severity of panniculitis associated with AAT deficiency.
AuthorsB Gross, M Grebe, M Wencker, J K Stoller, L M Bjursten, S Janciauskiene
JournalDermatology (Basel, Switzerland) (Dermatology) Vol. 218 Issue 4 Pg. 370-5 ( 2009) ISSN: 1421-9832 [Electronic] Switzerland
PMID19218787 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2009 S. Karger AG, Basel.
Chemical References
  • Polymers
  • alpha 1-Antitrypsin
Topics
  • Adult
  • Female
  • Humans
  • Panniculitis (drug therapy, etiology, pathology)
  • Phenotype
  • Polymers (analysis)
  • Skin (chemistry, pathology)
  • alpha 1-Antitrypsin (administration & dosage, analysis, genetics)
  • alpha 1-Antitrypsin Deficiency (complications, drug therapy, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: